MSA
XBI icon

Mason Street Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mason Street Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-635,910
Closed -$22.1M – 1782
2013
Q2 		$22.1M Buy
+635,910
New +$22.3M 0.24% 100

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Mason Street Advisors's XBI Position: Q3 2013 in Review

Mason Street Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2013, closing a stake of 635,910 shares — an estimated $22.1M sold.

Mason Street Advisors first reported a position in XBI in Q2 2013 and held it in 1 quarter. The position peaked at $22.1M in Q2 2013. 125 funds tracked by Wall St. Rank hold XBI as of Q3 2013.

  • Mason Street Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2013 after selling out during the quarter.
  • Mason Street Advisors sold 635,910 State Street SPDR S&P Biotech ETF shares in Q3 2013, an estimated $22.1M.
  • Mason Street Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 1 quarter.
  • Mason Street Advisors's State Street SPDR S&P Biotech ETF position peaked at $22.1M in Q2 2013.
  • 125 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2013.

Based on Mason Street Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.